The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

by Anna Thorsø Larsen, Sofie Gydesen, Nina Sonne, Morten Asser Karsdal, Kim Henriksen
Published 2021-01-01

Performance of claims-based algorithms for identifying incident thyroid cancer in commercial health plan enrollees receiving antidiabetic drug therapies

by Donnie Funch, Douglas Ross, Betsey M. Gardstein, Heather S. Norman, Lauren A. Sanders, Atheline Major-Pedersen, Helge Gydesen, David D. Dore
Published 2017-05-01

Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population

by Funch D, Mortimer K, Ziyadeh NJ, Seeger JD, Zhou L, Ng E, Ross D, Major-Pedersen A, Bosch-Traberg H, Gydesen H, Dore DD
Published 2021-06-01

Cortical Frontoparietal Network Dysfunction in CHMP2B-Frontotemporal Dementia

by Christian Sandøe Musaeus, Jette Stokholm Pedersen, Troels Wesenberg Kjær, Troels Wesenberg Kjær, Peter Johannsen, Gunhild Waldemar, Gunhild Waldemar, Maria Joy Normann Haverberg, Theis Bacher, Jørgen Erik Nielsen, Jørgen Erik Nielsen, Peter Roos, The FReJA Consortium, S Gydesen, J Brown, AM Isaacs, J Collinge, A Gade, E Englund, E Fisher, TT Nielsen, T Thusgaard, I Holm
Published 2021-09-01